RBR-76j763k招募中2 期
Treatment with Menadione in patients with Gastric Cancer in the Unified Health System
Hospital Ophir Loyola0 个研究点开始时间: 2022年11月9日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
- 年龄范围
- 19Y 至 0（—）
入选标准
- •Patients with locally advanced (T2, T3 or T4) and/or incurable disease; with a performance status between 0 and 2 according to the criteria defined by the Eastern Cooperative Oncology Group or greater than or equal to 60% by the Karnofsky performance status; with adequate organ and bone marrow functions and left ventricular ejection fraction above 50%
排除标准
- •Patients with brain metastases, angina, intestinal obstruction, active gastrointestinal bleeding and an estimated life of less than three months; with clinically significant comorbidities that may interfere with treatment tolerance and efficacy; on warfarin
研究者
相似试验
进行中（未招募）
1 期
Menthacarin® in the treatment of functional gastrointestinal disordersCTIS2022-501800-92-00Dr. Willmar Schwabe GmbH & Co. KG120
招募中
3 期
Ondansetron for symptoms of gastroparesis in patients with chronic kidney disease undergoing hemodialysisGastroparesis in patients with chronic kidney disease.OndansetronGastric accommodationHemodialysisChronic kidney diseaseGastroparesisTCTR20240712001Faculty of Medicine, Chiang Mai University72
进行中（未招募）
1 期
Treatment of gastrostomy related granuloma using hydrocortisone or tea tree oil: A randomized controlled trial. - Hydrocortisone versus Tea Tree oil in treating gastrostomy related granulomaEUCTR2007-001810-18-GBniversity Hospital Of North Staffordshire
进行中（未招募）
不适用
A Treatment Protocol for Patients with Gastrointestinal Stromal Tumor who are Ineligible for Participation in Other SU011248 Protocols AND are Refractory to or Intolerant of Imatinib Mesylate.Gastro-intestinal Stromal TumorsMedDRA version: 14.1Level: PTClassification code 10051066Term: Gastrointestinal stromal tumourSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2004-001860-27-ITPFIZER1,098
尚未招募
不适用
Combination therapy of paclitaxel, ramucirumab, and TEW7197 as a secondary treatment for gastric cancerNeoplasmsKCT0005928Samsung Medical Center43